 |
| Color: | |
|---|---|
| CAS NO: | |
| MF: | |
| MW: | |
Lgd 4033
Doublewin
1165910-22-4
Lgd 4033/Ligandrol
Name:LGD-4033
CAS: 1165910-22-4
MF:C14H12F6N2O
MW:338.2482992
Appearance: White fine powder
Applications:
LGD-4033 is in a group of androgen receptor (AR) ligands that are tissue selective, created to cure muscle wasting linked with acute and chronic diseases, age-related muscle loss and cancer.
It’s anticipated to yield the healing benefits of testosterone with better safety, admissibility and patient acceptance due to tissue-selective mechanism of action and its oral form of administering.
How LGD-4033 Works
LGD-4033 works by tying androgen receptors selectively. It shows anabolic activity in the bones and muscles instead of harmfully affecting the prostate and sebaceous glands which usually happens when using steroids. LGD-4033 just concluded a study called Phase I Multiple Ascending Dose which included fit volunteers. This was an unplanned, double bind analysis stage that included a placebo. The objective was to form that using LGD-4033 was harmless and easy to stomach with a dose not beyond 22 mg a day.
Clinical runs also showed that LGD-4033 has the ability to set off the following benefits when taken consistently:
An increase in strength levels
Lean muscle mass improved
A drop in body fat
Has healing properties
Does not cause the undesirable side effects caused by prohormones and anabolic steroids
Lgd 4033/Ligandrol
Name:LGD-4033
CAS: 1165910-22-4
MF:C14H12F6N2O
MW:338.2482992
Appearance: White fine powder
Applications:
LGD-4033 is in a group of androgen receptor (AR) ligands that are tissue selective, created to cure muscle wasting linked with acute and chronic diseases, age-related muscle loss and cancer.
It’s anticipated to yield the healing benefits of testosterone with better safety, admissibility and patient acceptance due to tissue-selective mechanism of action and its oral form of administering.
How LGD-4033 Works
LGD-4033 works by tying androgen receptors selectively. It shows anabolic activity in the bones and muscles instead of harmfully affecting the prostate and sebaceous glands which usually happens when using steroids. LGD-4033 just concluded a study called Phase I Multiple Ascending Dose which included fit volunteers. This was an unplanned, double bind analysis stage that included a placebo. The objective was to form that using LGD-4033 was harmless and easy to stomach with a dose not beyond 22 mg a day.
Clinical runs also showed that LGD-4033 has the ability to set off the following benefits when taken consistently:
An increase in strength levels
Lean muscle mass improved
A drop in body fat
Has healing properties
Does not cause the undesirable side effects caused by prohormones and anabolic steroids
